Search clinical trials for: Crohns+disease
Total 0 results
Nothing found
Sponsors and Collaborators
- ProteoSys AG
- AMTC & Associates
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- Fondren Orthopedic Group L.L.P.
- Elim Pediatric Pharmaceuticals Inc.
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- The Fifth Affiliated Hospital of Zunyi Medical College
- Celtaxsys Aus Pty Limited
- Victor Montori
- University Medical Center Goettingen
- Diego Hernan Giunta, MD
- Alberta Children's Hospital, Calgary, Canada
- Cardresearch
- CRMBM-CEMEREM
- Rui-hua Xu, MD, PhD
- Donders Institute for Brain, Cognition and Behavior
- San MediTech(Huzhou)Co.,Ltd.
- Norsk Proteinintolerance, Norway
- Societa Italiana di Endoscopia Digestiva
- Caritas Freetown
- View Full List
Medical Conditions
- Tube Disorders Eustachian
- Fever, Sweats, and Hot Flashes
- Gynecologic Cancer
- Disturbance of Activity and Attention
- Orbital Tumor
- Auditory Hallucination, Verbal
- Non-dystrophic Myotonias
- Prostate Cancer Recurrent
- Fibromyalgia Syndrome, Primary
- Lymphedema of Arm
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Normal Diameter of Optic Nerve
- Postcomatose Unawareness State
- Spermatogenesis Arrest
- Atrial Fibrillation, Postoperative
- Malignant Ascites Due to Epithelial Carcinoma
- Non-compressible Torso Hemorrhage
- Plasmodium Falciparum Malaria (Drug Resistant)
- Stereotactic Radioablation for Ventricular Tachycardia
- Tularaemia
- View Full List
Drug Interventions
- PF-00868554
- Atezolizumab
- SERETIDE Diskus
- Oxycodone, fentanyl
- Bortezomib/dexamethasone
- Methotrexate
- Enzalutamide, Abiraterone
- Mupirocin Calcium
- Ruxolitinib
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Insulin
- Flibanserin 100 mg dose every evening
- Lamivudine
- Topotecan
- Cytarabine ARA-C
- Polyethylene glycol 3350
- Cetrorelix 78 mg + 78 mg
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Indoximod
- Epimedium Prenylflavonoids Extract
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Armenia
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Croatia
- Contract Research Organizations in Djibouti
- Contract Research Organizations in France
- Contract Research Organizations in Gambia
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Jordan
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Uganda
- Contract Research Organizations in Zimbabwe
- CRO list by country